![Pharmaceuticals | Free Full-Text | Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus | HTML Pharmaceuticals | Free Full-Text | Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-12-00149/article_deploy/html/images/pharmaceuticals-12-00149-g008.png)
Pharmaceuticals | Free Full-Text | Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus | HTML
![Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia | SpringerLink Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40120-019-0138-z/MediaObjects/40120_2019_138_Fig2_HTML.png)
Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia | SpringerLink
![Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents | Molecular Psychiatry Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents | Molecular Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmp.2012.47/MediaObjects/41380_2012_Article_BFmp201247_Fig1_HTML.jpg)
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents | Molecular Psychiatry
![Frontiers | Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia | Behavioral Neuroscience Frontiers | Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia | Behavioral Neuroscience](https://www.frontiersin.org/files/Articles/62885/fnbeh-07-00140-HTML/image_m/fnbeh-07-00140-g007.jpg)
Frontiers | Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia | Behavioral Neuroscience
![Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20171002105054-89843-mediumThumb-S1092852917000608_fig9g.jpg?pub-status=live)
Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes | CNS Spectrums | Cambridge Core
![Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences - ScienceDirect Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0163725818301141-gr3.jpg)
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences - ScienceDirect
![Latuda (Lurasidone HCL Tablets for Oral Administration): Uses, Dosage, Side Effects, Interactions, Warning Latuda (Lurasidone HCL Tablets for Oral Administration): Uses, Dosage, Side Effects, Interactions, Warning](https://images.rxlist.com/images/rxlist/latuda4.gif)
Latuda (Lurasidone HCL Tablets for Oral Administration): Uses, Dosage, Side Effects, Interactions, Warning
![Lurasidone inhibits NMDA receptor antagonist‐induced functional abnormality of thalamocortical glutamatergic transmission via 5‐HT7 receptor blockade - Okada - 2019 - British Journal of Pharmacology - Wiley Online Library Lurasidone inhibits NMDA receptor antagonist‐induced functional abnormality of thalamocortical glutamatergic transmission via 5‐HT7 receptor blockade - Okada - 2019 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/8587a713-873b-408d-bd9d-c74b54239840/bph14804-fig-0011-m.jpg)
Lurasidone inhibits NMDA receptor antagonist‐induced functional abnormality of thalamocortical glutamatergic transmission via 5‐HT7 receptor blockade - Okada - 2019 - British Journal of Pharmacology - Wiley Online Library
![Pharmaceuticals | Free Full-Text | Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus | HTML Pharmaceuticals | Free Full-Text | Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-12-00149/article_deploy/html/images/pharmaceuticals-12-00149-g008-550.jpg)